On a single block of Broadway in Lower Manhattan, you can buy cannabis from three different sources: a state-licensed dispensary with a security guard and a digital menu board, a smoke shop with a neon “21+” sign and jars of unlabeled flower behind the counter, and a delivery service advertised on a laminated card tucked under your apartment door.
This is New York’s cannabis market in 2026 — a chaotic coexistence of legal and unlicensed operators that reflects every contradiction, compromise, and failure of the state’s legalization rollout. And despite the Office of Cannabis Management’s enforcement promises, the coexistence shows no signs of ending soon.
Two Markets, One City
New York’s adult-use cannabis program, authorized by the Marijuana Regulation and Taxation Act in March 2021, was designed to be the most equity-forward legalization framework in the country. Priority licensing for communities disproportionately affected by cannabis prohibition. A social equity fund to provide capital and technical assistance to qualified applicants. A deliberate exclusion of multi-state operators from the initial licensing rounds.
Five years later, the program has expanded to over 300 licensed dispensaries statewide, with roughly 180 in the five boroughs of New York City. Sales have ramped from a trickle in 2023 to approximately $800 million annually — a significant market by any measure, but far below the $4 billion to $7 billion that analysts projected at the time of legalization.
The gap between projection and reality has a simple explanation: the unlicensed market captured — and has held — a dominant share of cannabis sales in New York. Industry estimates suggest that unlicensed sales still account for 60% to 70% of total cannabis transactions in New York City, a figure that has improved from the estimated 90%+ in 2023 but remains stubbornly high.
Inside a Licensed Dispensary
The licensed dispensary experience in New York is, by most accounts, a significant improvement over what existed even 18 months ago. Early licensed stores struggled with limited product selection, high prices, and the operational challenges of launching in a regulatory environment that was still being written.
The current generation of licensed dispensaries offers a substantially different experience. Product selection has expanded to include flower, pre-rolls, edibles, concentrates, tinctures, and topicals from a growing roster of licensed cultivators and processors. Store designs range from sleek and minimalist to warm and community-oriented. Staff training has improved.
But the economics remain challenging. A licensed dispensary in New York City faces rent that can exceed $15,000 per month in commercial neighborhoods, mandatory security costs, comprehensive insurance requirements, seed-to-sale tracking compliance, and a 13% combined state and local tax on retail cannabis sales.
These costs create a price floor that the unlicensed market simply does not face. An eighth of premium flower at a licensed New York dispensary typically retails for $45 to $60. The same quantity — or what is marketed as the same quantity — is available from unlicensed sources for $25 to $35.
The Unlicensed Economy
New York’s unlicensed cannabis market is not a single entity. It is a layered ecosystem with distinct tiers, each operating with different levels of visibility, sophistication, and risk tolerance.
At the most visible level are the estimated 1,500 to 2,000 unlicensed smoke shops and storefronts that continue to sell cannabis products openly throughout the city. The OCM has conducted enforcement operations against hundreds of these locations, issuing padlock orders and seizing product. But the enforcement has resembled a game of whack-a-mole: closed shops reopen under new names, move to new locations, or simply resume operations after paying fines that amount to a cost of doing business.
Below the storefronts is a delivery market that has grown more sophisticated over time. Services operate through encrypted messaging apps, purpose-built ordering platforms, and social media accounts, offering same-day delivery with a speed and convenience that most licensed dispensaries cannot match. Some delivery services have developed loyal customer bases through consistent quality, reliable timing, and reward programs.
The illicit market’s persistence is not simply a matter of price, though price is the most significant factor. Convenience, product variety (including products not available through legal channels), and the absence of the data collection required at licensed dispensaries (which require scanning government-issued ID) all contribute to continued consumer preference for unlicensed sources.
Social Equity Licenses
The social equity licensing program — the moral centerpiece of New York’s legalization framework — has produced results that are both meaningful and insufficient.
Over 150 Conditional Adult-Use Retail Dispensary (CAURD) licenses have been awarded to applicants who met the program’s equity criteria: prior cannabis conviction or family member with a conviction, combined with ownership of a small business. Many of these licensees have opened operational dispensaries, some in prime retail locations secured through the state’s partnership with the Dormitory Authority of the State of New York (DASNY), which used public funds to build out retail spaces for equity licensees.
The program created real opportunities for individuals and communities that the war on drugs devastated. Several equity licensees have built thriving businesses, hired locally, and become visible anchors in their neighborhoods.
But the program’s structural challenges have been well-documented. The DASNY buildout process was plagued by delays, cost overruns, and location disputes. Some equity licensees received keys to dispensaries that were months behind schedule and over budget. Access to capital remained the single largest barrier — equity licensees without personal wealth or investor relationships struggled to fund inventory, staff, and marketing in the critical early months of operation.
The OCM’s administrative capacity was overwhelmed by the scale of the licensing task. Application processing backlogs stretched to months, and the regulatory uncertainty created a Catch-22: investors were reluctant to commit capital to businesses whose licenses were still pending, and licensees could not operate without capital.
What Other States Can Learn
New York’s experience offers several lessons for states that are earlier in the legalization process — lessons that are uncomfortable but important.
First, the pace of licensed market rollout must match or exceed the pace of demand. New York’s decision to prioritize equity licensing over speed of market development was philosophically sound but practically self-defeating. The slow rollout of licensed retail gave the unlicensed market years to entrench, establish customer relationships, and demonstrate that enforcement alone cannot dislodge an established supply chain.
Second, price competitiveness with the unlicensed market is not optional. States that impose tax rates and regulatory costs that push legal prices significantly above illicit market prices are ensuring their legal markets will struggle for market share. Oregon’s approach — relatively low taxes and high license availability — drove illicit market share below 30% within three years. New York’s approach — moderate taxes but high compliance costs and limited initial supply — has not achieved the same result.
Third, social equity programs require operational support, not just licensing priority. A license without capital, mentorship, and regulatory guidance is a piece of paper. The states that have paired licensing priority with comprehensive support programs — Illinois’s Social Equity Justice Involved Fund, for example — have seen better outcomes for equity licensees, though no program has fully closed the resource gap.
The Path Forward
New York’s cannabis market is improving. Licensed dispensary counts are growing. Product quality and selection are expanding. The OCM’s enforcement operations, while imperfect, have reduced the visibility of unlicensed storefronts in some neighborhoods. Consumer awareness of the licensed market is increasing.
But the structural challenges that created the current two-market reality — high compliance costs, slow licensing, an entrenched unlicensed economy, and a tax structure that favors the illicit market on price — will take years to fully resolve. New York will eventually build a functional legal cannabis market. It will just take longer, cost more, and produce more political drama than anyone anticipated when the MRTA was signed in 2021.
For the operators, regulators, and advocates who have invested years in making New York’s legal market work, the frustration is real but the trajectory is correct. The question is whether the state has the patience and political will to see it through — or whether the compromises necessary to accelerate the transition will erode the equity principles that made New York’s legalization framework distinctive in the first place.